NextGen Omics, Spatial & Data 2025
Novotel London West, London, UK
From Novel Technologies to Clinical Applications: Driving the Next Generation of Multi-Omics Research
Highlights of the Two-Day Event
13 - 14 November 2025 | London, UK
Join Cell 2025 — where next-gen cell culture, bioprocessing, and therapeutic innovation converge to accelerate the future of cell & gene therapies.
Step into the epicentre of advanced therapy innovation at Cell 2025, Oxford Global’s premier event for the cell culture and cell & gene therapy community. From discovery through to commercialisation, this is where science meets strategy—and game-changing ideas are born.
Spanning three powerhouse programmes, the event offers the ultimate platform to explore the entire value chain. Whether you’re scaling production, fast-tracking development, or pushing the boundaries of AI in manufacturing, this is where the next generation of therapies takes shape.
Cell Culture & Bioprocessing Programme — advancing stable, scalable, and high-performing cell systems through cutting-edge engineering, next-gen bioprocessing, and 3D culture innovations.
Advanced Therapy Development Programme — accelerating the path from scientific discovery to clinical impact with breakthrough gene & cell therapy research, robust analytics, and regulatory-ready strategies.
Cell & Gene Therapy Manufacturing Programme — enabling the next generation of therapies through intelligent manufacturing, integrated supply chains, and AI-enhanced production platforms.
Expect bold ideas, brilliant minds, and breakthrough technologies. With cutting-edge presentations, C-suite keynotes, investor spotlights, and curated showcases, Cell 2025 isn’t just a conference—it’s your gateway to the future of bioprocessing and cell & gene therapy.
Cross-Programme Highlights of the event:
Mihaela Van Der Schaar, John Humphrey Plummer Professor of Machine Learning, Artificial Intelligence & Medicine, University of Cambridge
David Bentley, Professor, Department of Biochemistry & Molecular Genetics, former Co-Director of University of Colorado RNA Biosciences Initiative, University of Colorado School of Medicine
Globally recognised leaders in Artificial Intelligence, Professor Mihaela Van Der Schaar & Professor David Bentley will take the stage to discuss the unprecedented advancements in artificial intelligence have the potential to refine, challenge, and even rewrite our understanding of human biology. Their presentation “Rewriting the Rules of Life: Discovering, Challenging, & Extending Biological Dogma with AI” will explore how AI-driven insights are leading to biological hypotheses with the potential to reshape conventional thinking. They will also candidly reflect on the challenges of AI adoption and how to best overcome these to inspire collaboration between the AI and biology communities.
Professor Matthew Cobb, University of Manchester
Join Matthew, author of publications including the Royal Society Winton Prize shortlisted ‘Life’s Greatest Secret: The Story of the Race to Crack the Genetic Code’; ‘The Genetic Age’; and Sunday Times’ Book of the Year winner The Idea of the Brain as he delves into his latest work “How the Double Helix was Really Discovered: Watson, Crick, Franklin, & Wilkins” investigating and recontextualising the discovery of the double helix with new evidence and interpretations.
Beyond our keynote addresses and fireside chats, our cross-programme panel panels unite leading experts from across the multi-omics ecosystem. Held just after lunch each day, these dynamic, multi-stakeholder discussions tackle some of the most pressing challenges and transformative developments shaping the future of omics research. Through cross sector collaboration and fresh perspectives, these panels will drive forward new solutions for advancing patient centric healthcare.
Cross Programme Panel Discussion: The Role of Multi-Omics in Advancing Precision Therapeutics
Join representatives from BMS, AstraZeneca, & The University of Oxford & more to discuss the potential of omics research in the development of precision therapeutics with insights from representatives working with liquid biopsies, spatial analysis, single cell analysis, and data science.
Cross Programme Panel Discussion: The Year of Multi-Omics? 2025 in Review
As we round out the year, join this panel to take a look back at the advancements made in multi-omics in 2025 and help experts set the scene for further developments in 2026 and beyond.
Cross Programme Panel Discussion: Patient Participation in Multi-Omic Studies
Patient care remains the central force of all medical research, and this session will bring together patient engagement professionals, academic researchers, and pharmaceutical professionals to discuss strategies to ensure patient safety, protection, inclusion & diversity.
Hear who is awarded the top 5 places at our young scientist poster awards as we kick off our networking drinks on the 13th and hear them present their work on day 2, just after the lunch break.
Joanna Howson, Scientific Vice President, NovoNordisk
Having built up all the human genetics research at Novo Nordisk and transformed this area into one of the company’s key pipelines, Joanna will take to the stage to examine the role of genomics in the pharmaceutical industry and the potential it holds for the future. This session will chart a course for the next steps in the utilisation of multi-omics data within the pharmaceutical industry and consider some of the key hurdles that remain to be overcome.
Mark your calendars for our breakfast roundtables on day two of the event. Join in from 08:15 – 09:00am to discuss key topic areas with one of our 8 experts in a lively, informal, setting whilst you secure yourself a coffee and a pastry for the day ahead.
Hosted by Partick Descombes, Senior Expert, Genomics at Nestle and Massimo Delledonne, Professor at the University of Verona, the Multi-Omics Technologies Overview & Updates workshop is an extended 75-minute session. Tailored to what attendees have voted their most wanted topics, the workshop will delve into the development of the technologies that are shaping the omics field. Let us know what you want to hear when you register!
Cell Culture & Bioprocessing Programme:
- Panel Discussion: Novel Formats For Cell Line Engineering - Vincenzo Di Cerbo, Lead Scientist, Cell and Gene Therapy Catapult
- Panel Discussion: Streamlining Bioprocessing: Automation & Integration In Downstream Workflows - Parag Kumthekar, Gene Therapy Downstream Process Development Lead, UCB; Cristina Peixoto, Head Of Downstream Process Development Lab, iBET
- Panel Discussion: Overcoming The Challenges Of Moving From In Vivo, In Vitro To 3D Cell Models - Rhiannon David, Director, Advanced Cell Models / Microphysiological Systems, AstraZeneca; Aline Miller, Professor, University of Manchester; Maryna Panamarova, 3D Cellular Modelling Specialist, Cellular Operations, Wellcome Sanger Institute; Giacomo Domenici, Research Scientist, iBET
Advanced Therapy Development Programme:
- Panel Discussion: Experiences In Executing Cell & Gene Therapy Studies With Patient Engagement In Mind - Panteli Theocharous, Chief Therapeutics Officer & Head Of Medical & Scientific Affairs, Garuda Therapeutics; Terri Gaskell, Chief Technology Officer, Rinri Therapeutics; Joanna Brewer, Chief Scientific Officer, Adaptimmune; Nitin Patel, Vice President Of Late-Stage Clinical Development, Legend Biotech
- Presentation: Clinical Development Of Engineered TCR-T Therapies To Generate A Sarcoma Franchise - Joanna Brewer, Chief Scientific Officer, Adaptimmune
Cell & Gene Therapy Manufacturing Programme:
- Panel Discussion: Bridging The Gap Between R&D And Manufacturing For Digital & Automation Solutions - Tiffany Rau, Professor Biochemistry & Cell Biology, University College Cork; Daria Marsh, Head of Bioprocessing, Cell & Gene Catapult; Lydia Caro, Associate Director, Head Of Cell Sciences, Ichnos Sciences
- Presentation: Smart Manufacturing – Thorsten Gorba, Vice President Process & Analytical Development, Aspen Neuroscience
With 150+ speakers representing large pharmaceutical companies, emerging biotechs & renowned academic institutions, we are proud to welcome over 45 award-winning experts across the 2 programmes:
• Shadi Farhangrazi, Chief Executive Officer of S.M. Discovery Group, received the 2018 BioInnovation Award for her work in drug discovery
• Christoph Rösli, Director of Research Bern at CSL Behring, received the 2021 Swiss Biotech Success Stories Award for his contributions to biotechnology research.
• Vineeta Tripathi, Chief Executive Officer of Vitarka Therapeutics, received the 2019 Women in Bio Entrepreneurial Leadership Award for her work in biotech entrepreneurship
• Stephen Pham, Senior Vice President at Avalyn Pharma, was awarded the 2019 Respiratory Innovation Award
• Emma Mead, Chief Scientific Officer at Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford, was honoured with the 2020 Alzheimer's Research UK Young Investigator of the Year Award for her work in neurodegenerative disease research.
• Raul Rodriguez, Vice President at Woxsen University, received the 2021 Entrepreneur of the Year Award for his contributions to education in the biotech field.
• Philip Hewitt, Global Head of Early Investigative Toxicology at Merck, was honoured with the Society of Toxicology's 2018 Achievement Award for his significant impact in toxicological research.
.jpg?width=2819&height=1174&name=74dfee8e-75c7-46e0-9f51-31b709af2ede-2-5668375logo-Nanion_logo_black_RGB_300dpi-(2).jpg){kind=logo}
Connect and Network
Experience an event that celebrates meaningful, one-on-one connections in a dynamic, bustling atmosphere.
With NextGen Omics, Spatial & Data 2025, enjoy a vibrant crowd with the warmth of personal interactions and curated experiences